Indications and uses
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
dosage should be taken one hour before travel starts for 25 mg: adults and children 12 years and over, take 1 or 2 tablets once daily or directed by a doctor for 12.5 mg: adults and children 12 years and over, take 2 or 4 tablets once daily or directed by a doctor
12.5 mg Tablet: Meclizine HCl 12.5 mg
25 mg Tablet: Meclizine HCl 25 mg
Purpose
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
for 25 mg: adults and children 12 years and over, take 1 or 2 tablets once daily or directed by a doctor
for 12.5 mg: adults and children 12 years and over, take 2 or 4 tablets once daily or directed by a doctor
magnesium sterate, microcrystalline cellulose, silicon dioxide, lactose monohydrate
Store at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Call 1-844-474-7464
Do not use in children under 12 years of age unless directed by a doctor
Do not take this product, unless directed by a doctor, if you have
Do not take this product if you are taking sedatives or tranquilizers, without first consulting your doctor.
If pregnant or breast-feeding, ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center immediately (1-800-222-1222).
Manufactured by:
Aurex laboratories LLC
East Windsor, NJ 08520
Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816
Revised:08/2021
Meclizine HCl Tablets
25 mg
100
Meclizine HCl Tablets
12.5 mg
100
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16571-751-01 | EA - Each | 16571-751 | e9775eea-36e1-40ca-8dbb-119b3f803cd5 | 1 | 2023-05-05 |
| 16571-752-01 | EA - Each | 16571-752 | 2aa5cc45-df03-424f-8cab-224a41034762 | 1 | 2023-05-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 16571-751 | 16571-751-01 |
| 16571-752 | 16571-752-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| MECLIZINE HYDROCHLORIDE | HDP7W44CIO | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 5955ab7d-5927-4092-91ed-fa9b21b86b1a | 7f375ef7-1bb7-412f-b097-0d350e27dbf8 | 2023-07-12 | Warnings | 7f375ef7-1bb7-412f-b097-0d350e27dbf8 |
Adverse event summaries are temporarily unavailable. Other product information remains available.